Shinil Pharmaceutical rises 5.4% amid COVID-19 (Dexamethasone) theme uptrend

On the 14th, the COVID-19 (Dexamethasone) theme rose 3.14% compared to the previous day, showing strength, while Shinil Pharmaceutical, which is attracting attention as a related stock, surged 5.4% compared to the previous day. Shinil Pharmaceutical is known as a finished pharmaceutical product manufacturer.

[Graph] Major stock price changes in the COVID-19 (Dexamethasone) theme

According to provisional data compiled at 11:31, foreigners are net selling -6,900 shares of Shinil Pharmaceutical.

[Table] Net trading volume of foreigners and institutions (unit: 10,000 shares)

According to the analysis by Thinkpool Robo Algorithm RASSI, Shinil Pharmaceutical exceeded the average scores of the theme in growth, stability, and profitability, ranking 6th in the quant financial ranking (out of 15 stocks). This can be interpreted as Shinil Pharmaceutical having relatively high investment attractiveness compared to other stocks within the theme from a financial perspective.

[Table] Top stocks by financial score within the theme

※ The quant financial score is the result of the Robo Algorithm analyzing each company's sales growth rate, equity growth rate, debt ratio, current ratio, ROA, ROE, etc.

※ This article was generated in real-time by an automated article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.

This content was produced with the assistance of AI translation services.